An assessment of changes in total kidney function (using GFR measurement), regional kidney functional change (using SPECT imaging) and their correlation with radiotherapy dose delivery is within the means of currently available imaging, therapy and computational technology.
A panel of clinical laboratory blood tests was measured to assess for effects of 18F-TFB administration on blood chemistries, including electrolytes, and liver and kidney functional tests.
However, translation of successful novel therapies designed to attenuate kidney functional injury from animal models to the clinical sphere has had modest results.
Li+ also caused distortion in normal renal, cerebral and cerebellum architecture and significantly worsened all kidney functional parameters tested compared to control.
These findings impact both in vitro bioreactor-based kidney functional and regenerative medicine models, as well as high-throughput cell-based drug screening validations.
These issues encompassed diagnostic challenges, management of kidney functional decline and progression of chronic kidney disease, challenges in clinical study design, translation of advances in research to clinical care, and provision of practical and integrated patient support.
Therefore, the disturbed kidney functional parameters may have been inducedby the reduced levels of phenolic acids in the GM maize feed used in our study, sincecaffeic and ferulic acids are beneficial to the kidney as they prevent oxidative stress [38, 39].
The secondary pre-specified outcome of the study (safety) was assessed by the collection of all adverse events occurred during the study, including any significant change in haematological (including coagulation assessment), biochemical (with liver and kidney functional parameters) and immunological parameters (including CD4+, CD8+, CD3+ T cells, NK, B cells and monocytes).
The activities of liver and kidney functional markers were measured.
